| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/08/2010 | WO2010038688A1 Particulate pharmaceutical composition for oral administration of atorvastatin |
| 04/08/2010 | WO2010038686A1 Novel fused aminodihydrothiazine derivative |
| 04/08/2010 | WO2010038656A1 Prophylactic and therapeutic agent for sepsis |
| 04/08/2010 | WO2010038647A1 Adhesive patch and adhesive patch kit |
| 04/08/2010 | WO2010038465A1 8-substituted isoquinoline derivative and use thereof |
| 04/08/2010 | WO2010038434A1 Process for production of optically active hexahydropyrroloquinoline and intermediate for the process |
| 04/08/2010 | WO2010038428A1 Alternative agent to taxane anti-cancer agent |
| 04/08/2010 | WO2010038241A2 Pharmaceutical compositions comprising of proton pump inhibitor, prokinetic agent and alginic acid |
| 04/08/2010 | WO2010038240A1 Pharmaceutical composition comprising nimesulide and levocetirizine |
| 04/08/2010 | WO2010038200A1 Oxazolidine compounds as orexin receptor antagonists |
| 04/08/2010 | WO2010038167A1 Oxopiperidinyl and pyranyl sulfonamides as ampa potentiators |
| 04/08/2010 | WO2010038165A1 Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions |
| 04/08/2010 | WO2010038153A1 Use of sox transcription factor acti\ators for stimulating chondrogenesis |
| 04/08/2010 | WO2010038129A1 Mucomimetic compositions and uses therefore |
| 04/08/2010 | WO2010038115A1 Novel nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments |
| 04/08/2010 | WO2010038081A2 Heterocyclic derivatives and methods of use thereof |
| 04/08/2010 | WO2010038078A2 Nitrotyrosine assay |
| 04/08/2010 | WO2010038060A1 Heterocyclic jak kinase inhibitors |
| 04/08/2010 | WO2010037892A1 Composition comprising silibinin at determined concentrations and combined preparation comprising silibinin and a pi3k/akt pathway inhibitor for the treatment of cancer |
| 04/08/2010 | WO2010037886A1 Chroman derivatives and uses thereof as inhibitors of the activity of decoupling proteins |
| 04/08/2010 | WO2010037849A1 Duloxetine enteric pellets |
| 04/08/2010 | WO2010037785A2 Inhibitors of f18+ e coli binding |
| 04/08/2010 | WO2010037765A2 4-morpholino-pyrido[3,2-d]pyrimidines |
| 04/08/2010 | WO2010037760A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 04/08/2010 | WO2010037728A2 Novel ezetimibe formulations |
| 04/08/2010 | WO2010037723A1 Compounds which have activity at m1 receptor and their uses in medicine |
| 04/08/2010 | WO2010037718A1 Methods and compounds for testing binding of a ligand to a g protein-coupled receptor |
| 04/08/2010 | WO2010037715A1 Smoothened antagonism for the treatment of hedgehog pathway-related disorders |
| 04/08/2010 | WO2010037566A1 Improved nanoparticulate compositions of poorly soluble compounds |
| 04/08/2010 | WO2010037536A1 N-protected guanidine-substituted furans, thiophenes, and pyrrols as cysteine protease inhibitors |
| 04/08/2010 | WO2010037533A1 Glycine b antagonists |
| 04/08/2010 | WO2010037398A1 Oral formulation |
| 04/08/2010 | WO2010037339A1 Aminoquinazoline derivatives and their salts with antineoplastic activity |
| 04/08/2010 | WO2010037271A1 A group of amino substituted benzoyl derivatives and their preparation and their use |
| 04/08/2010 | WO2010037269A1 The use of hirsutine in preparation of medicaments for treating myocardial damage |
| 04/08/2010 | WO2010037257A1 New benzazepine compounds, preparation methods and uses thereof |
| 04/08/2010 | WO2010037252A1 Sulfated derivative of gastrodia elata polysaccharide, preparation method and use thereof |
| 04/08/2010 | WO2010037249A1 5,8-disubstituted-1,6-naphthyridine-7-carbonyl amide compounds, their preparation methods, compositions and use |
| 04/08/2010 | WO2010037225A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/08/2010 | WO2010037210A1 Viral polymerase inhibitors |
| 04/08/2010 | WO2010037207A1 Selective glycosidase inhibitors and uses thereof |
| 04/08/2010 | WO2010037180A1 Anionic oligosaccharide conjugates |
| 04/08/2010 | WO2010037179A1 Anionic conjugates of glycosylated bacterial metabolite |
| 04/08/2010 | WO2010037173A1 Bile acids and biguanides as protease inhibitors for preserving the integrity of peptides in the gut |
| 04/08/2010 | WO2010037172A1 Antioxidant compounds and methods of their use |
| 04/08/2010 | WO2010018231A3 Salt of, and processes for the preparation of, 1-isopropyl-4-{[4-(tetrahydro-2h-pyran- 4-yloxy)phenyl]carbonyl}hexahydro-1h-1,4-diazepine |
| 04/08/2010 | WO2010017122A3 Methods of treating thalassemia |
| 04/08/2010 | WO2010015932A3 System for protection of plants from pathogens using alkamides |
| 04/08/2010 | WO2010011686A3 Amides as inhibitors of human secreted phospholipase a2 |
| 04/08/2010 | WO2010011289A3 Parenteral and oral formulations of benzimidazoles |
| 04/08/2010 | WO2010007331A3 Composition of soluble indigestible fibre and of microalgae used in the well-being field |
| 04/08/2010 | WO2010007318A3 Imidazo [1, 2-a] pyrimidine derivatives method for the production thereof application thereof as medicaments pharmaceutical compositions and use thereof as met inhibitors |
| 04/08/2010 | WO2010007248A3 Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 04/08/2010 | WO2010006234A3 Anticancer oral formulation |
| 04/08/2010 | WO2010006172A3 2-methylene-20(21)-dehydro-19-nor-vitamin d analogs |
| 04/08/2010 | WO2010005534A3 Proteasome inhibitors for selectively inducing apoptosis in cancer cells |
| 04/08/2010 | WO2010004433A3 Hydrophobically enhanced aminoglycosides |
| 04/08/2010 | WO2010003465A3 A drug powder for inhalation administration and a process thereof |
| 04/08/2010 | WO2010001096A3 Treatment |
| 04/08/2010 | WO2009156675A3 Novel depigmenting compositions in the form of a petroleum jelly-free and elastomer-free anhydrous composition comprising a solubilized phenolic derivative and a retinoid |
| 04/08/2010 | WO2009156092A3 Bi-and polycyclic substituted isoquinoline and isoquinoline derivatives as rho kinase inhibitors |
| 04/08/2010 | WO2009155504A9 Methods for the modulation of angiogenesis |
| 04/08/2010 | WO2009155488A3 Novel oxalate salt and crystal of o-desmethylvenlafaxine |
| 04/08/2010 | WO2009153665A3 Inhibitors of the shiga toxins trafficking through the retrograde pathway |
| 04/08/2010 | WO2009151529A9 Novel modulators of sphingosine phosphate receptors |
| 04/08/2010 | WO2009133294A3 Molecules inhibiting a metabolic pathway involving the syk protein tyrosine kinase and method for identifying said molecules |
| 04/08/2010 | WO2009129509A4 Methods and compositions for treating post-operative pain comprising a local anesthetic |
| 04/08/2010 | WO2009129453A4 Clonidine formulation in a polyorthoester carrier |
| 04/08/2010 | WO2009129437A4 Methods and compositions for treating post-operative pain comprising clonidine |
| 04/08/2010 | WO2009127669A3 Ido inhibitors and therapeutic uses thereof |
| 04/08/2010 | WO2009122303A3 Novel mandelate salt of fesoterodine |
| 04/08/2010 | WO2009120615A3 Substituted gamma lactams as therapeutic agents |
| 04/08/2010 | WO2009115614A3 Von willebrand factor specific binders and methods of use therefor |
| 04/08/2010 | WO2009101458A3 New polymorph and amorphous forms of desvenlafaxine fumarate |
| 04/08/2010 | WO2009053763A8 New non-peptide derivatives as bradykinin b1 antagonists |
| 04/08/2010 | WO2009050291A3 Solid dispersion product of n-aryl urea-based drugs |
| 04/08/2010 | WO2009018662A9 Renin inhibitors |
| 04/08/2010 | WO2009013480A8 Antibacterial combination therapy |
| 04/08/2010 | WO2009002490A3 Formulations of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxamide |
| 04/08/2010 | WO2008014266A9 Heme oxygenase inhibitors and methods of therapeutic use |
| 04/08/2010 | US20100088778 Methods of Treatment, and Diagnosis of Epilepsy by Detecting Mutations in the SCN1A Gene |
| 04/08/2010 | US20100088775 Methods of modulating epithelial-mesenchymal transition and mesenchymal-epithelial transition in cells and agents useful for the same |
| 04/08/2010 | US20100087853 Compositions and methods for use of alginate dural sealants |
| 04/08/2010 | US20100087795 Self-learning drug delivery system |
| 04/08/2010 | US20100087768 Transdermal drug delivery system for liquid active ingredient |
| 04/08/2010 | US20100087651 New mandelic acid derivatives and their use as thrombin inhibitors |
| 04/08/2010 | US20100087547 Use of a Blood-Flow Decrease Preventing Agent in Conjunction With Insufflating Gas |
| 04/08/2010 | US20100087546 Use of dimethyl sulfone (msm) to reduce homocysteine levels |
| 04/08/2010 | US20100087545 Purification process |
| 04/08/2010 | US20100087544 N, n -dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same |
| 04/08/2010 | US20100087543 Pharmaceutical use of substituted amides |
| 04/08/2010 | US20100087541 Compounds for the treatment of metabolic disorders |
| 04/08/2010 | US20100087540 Pharmaceutical composition |
| 04/08/2010 | US20100087539 N'--3-amino-3-phenylpropeonic acid and the pharmaceutically acceptable derivatives thereof, a method for the production and the use thereof in the form of a medicinal agent |
| 04/08/2010 | US20100087538 Drug substance preparations, pharmaceutical compositions and dosage forms |
| 04/08/2010 | US20100087537 Reduced irritant enema for the treatment of inflammatory bowel disease (ibd) |
| 04/08/2010 | US20100087536 Amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof |
| 04/08/2010 | US20100087535 External composition for skin |
| 04/08/2010 | US20100087534 Use of a Photosensitizing Agent in the Treatment or Prevention of an Inflammation-Associated Disorder in the Gastrointestinal Tract of a Mammal |
| 04/08/2010 | US20100087533 Composition |